Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Yuan Z et al. – Cell lines with an EGFR 3'–UTR mutation and that were wild–type (WT) for downstream signaling mediators in the Ras/BRAF and PIK3CA/PTEN pathways were sensitive to EGFR inhibition, whereas those harboring mutations in these signaling mediators were not. Furthermore, in cell lines WT for downstream signaling mediators, those with EGFR 3'–UTR mutations were more sensitive to EGFR inhibition than EGFR 3'–UTR WT cells, suggesting that this mutation provides a growth advantage to this subset of MSI colon tumors.

Today in Colorectal Cancer/Polyps...keeping you current

Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression
Genes, Chromosomes and Cancer, 12/19/09

TGFB1 509 C/T polymorphism and colorectal cancer risk: a meta-analysis
Medical Oncology, 12/17/09

A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells
Cancer Chemotherapy and Pharmacology, 12/17/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address